Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-21-013660
Filing Date
2021-07-19
Accepted
2021-07-19 19:03:09
Documents
1
Period of Report
2021-07-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 4077
  Complete submission text file 0001567619-21-013660.txt   5628
Mailing Address 329 OYSTER POINT BLVD., 3RD FLOOR SOUTH SAN FRANCISCO CA 904080
Business Address 329 OYSTER POINT BLVD., 3RD FLOOR SOUTH SAN FRANCISCO CA 904080 650 325 5156
Imago BioSciences, Inc. (Issuer) CIK: 0001623715 (see all company filings)

EIN.: 454915810 | State of Incorp.: DE | Fiscal Year End: 1214
SIC: 2834 Pharmaceutical Preparations

Mailing Address 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199
Business Address 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199 617-502-6538
Omega Fund VI, L.P. (Reporting) CIK: 0001757917 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40604 | Film No.: 211098973